Pacira BioSciences, Inc.
PCRX · FY2025 · Fiscal year ended Dec 31, 2025 · 10-K filed Feb 2026
Open the dashboardInfographicSummary
FY2025 key figures
| $ | FY2025 | FY2024 | Change |
|---|---|---|---|
| Revenue | $726M | $701M | +3.6% |
| Operating income | $19.2M | −$73.4M | |
| Net income | $7.03M | −$99.6M |
Latest quarter: Q3 2026
Form 10-Q · Three months ended Sep 30, 2026 · filed Nov 5, 2026
| $ | Q3 2026 | Year earlier | Change |
|---|---|---|---|
| Revenue | $177M | $180M | −1.6% |
| Operating income | $22.3M | $6.40M | +248% |
| Net income | $28.5M | $5.40M | +428% |
Q3 2026 dashboardQ3 2026 infographic
Questions
- What was Pacira's revenue in FY2025?
- $726M in FY2025 (Fiscal year ended Dec 31, 2025), +3.6% vs $701M a year earlier, per its 10-K filed Feb 2026.
- Was Pacira profitable in FY2025?
- Yes: net income was $7.03M and operating income $19.2M in FY2025.
- What was Pacira's revenue in Q3 2026?
- $177M (−1.6% vs a year earlier), per its Form 10-Q filed Nov 5, 2026.